BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.
Serving global pharmaceutical and biotech firms, donor organizations and biobanks as well as research and academic organizations, BioStorage Technologies’ 18,000 square-foot (1,672 square-meter) biorepository, uses an estimated 360,000-kilowatt hours (kWh) of power per year. By using 100 percent renewable energy, BioStorage Technologies is preventing the generation of an estimated 189 tons of environmentally harmful carbon dioxide (CO2) in the first year, thus making a valuable contribution to environmental protection. As the European operation grows, the amount of carbon dioxide prevented from generation will increase significantly.
“We are pleased to have all of our global facilities operating with 100 percent renewable energy,” said F. John Mills, M.D., Ph.D., chairman and chief executive officer at BioStorage Technologies. “This initiative demonstrates our commitment to conserving energy and improving the health of the environment by decreasing carbon dioxide emissions.”
Dr. Wolfgang Höffer, managing director of BioStorage Technologies’ European operations, adds, “Using renewable energy is only one of the green initiatives underway at our facilities. Additional aspects of the initiative include environmentally conscious management of waste disposal, logistics, water consumption and paper use.” BioStorage Technologies is also researching low VOC (Volatile Organic Compound) cleaning agents, the use of fair-trade products where applicable and other ways of making facilities and services better for the overall health of individuals and the environment.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.